E. Rivera
Universitat Pompeu Fabra · 24 works · 202 citations · h-index 6
Top works
- Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.
- Phase III study of docetaxel weekly (DW) versus every 3 weeks (D) in patients with metastatic breast cancer: Final results
- Goserelin plus anastrozole in the treatment of premenopausal hormone receptor positive, recurrent or metastatic breast cancer
- Weekly high-dose paclitaxel(HD-P) has significant antitumor activity in inflammatory breast cancer (IBC)
- Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel
- Randomized trial of yoga in women with breast cancer undergoing radiation treatment
- Phase I combination study of trabectedin and capecitabine in patients with advanced malignancies
- Taxanes in metastatic breast cancer patients with impaired liver function
- Identification of Docetaxel in Tears from Patients with Metastatic Breast Cancer
- Phase I trial of escalating doses of weekly everolimus (RAD001) in combination with docetaxel for the treatment of metastatic breast cancer (MBC)
- Phase I combination study of trabectedin (T) and capecitabine (C) in patients with advanced malignancies
- Actualización BI-RADS® v2025: cambios clave en el léxico de la imagen mamaria
- Abstract OT3-3-01: Eniluracil + 5-fluorouracil + leucovorin (EFL) vs. capecitabine phase 2 trial for metastatic breast cancer
- Comparison of first-course PET scan against fourth-course MRI for early detection of poor responders to neoadjuvant chemotherapy (NAC) for breast cancer (BC).
- 1002
- Epigenetic therapy with valproic acid, an HDAC inhibitor, in refractory/relapsed non-Hodgkin lymphoma (NHL) and Hodgkin disease.
- Comparison of MammaPrint and TargetPrint with clinical parameters in patients with breast cancer: Findings from a prospective U.S. cohort.
- Factors associated with participation in breast cancer treatment
- Asociación de la alta densidad mamaria a efectos adversos del programa de cribado en cáncer de mama: estudio retrospectivo
- A case study from M.D. Anderson Cancer Center: 26-year-old female with self-palpated axillary adenopathy